Crossmark

Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults

Crossref DOI link: https://doi.org/10.1038/s41598-019-48554-x

Published Online: 2019-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Madempudi, Ratna Sudha https://orcid.org/0000-0003-1819-722X
Ahire, Jayesh J.

Neelamraju, Jayanthi

Tripathi, Anirudh

Nanal, Satyavrat
License Information

Text and Data Mining valid from 2019-08-21

Version of Record valid from 2019-08-21
More Information

Article History

Received: 25 October 2018

Accepted: 5 August 2019

First Online: 21 August 2019

Competing Interests

: R.S.M., J.J.A. and J.N. are employed by Unique Biotech Ltd. which is a manufacturer of probiotics. They wish to state that the study was conducted independently with no intervention on their part during the duration of the study.

Document is current

Any future updates will be listed below